The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fiserv Inc
SWB:FIV
|
US |
|
B
|
Banque Cantonale de Geneve
SIX:BCGE
|
CH |
|
F
|
Federated Hermes Inc
F:3KC
|
US |
|
Bandai Namco Holdings Inc
OTC:NCBDF
|
JP |
|
A
|
Avient Corp
XMUN:PY9
|
US |
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
Atlas Arteria Group
ASX:ALX
|
AU |
|
N
|
Neogenomics Inc
F:NG9
|
US |
|
N
|
Narrowstep Inc
OTC:NRWS
|
US |
|
M
|
McCormick & Company Inc
SWB:MCX
|
US |
|
J
|
Jiangxi Copper Co Ltd
SWB:JIX
|
CN |
|
N
|
Nippon Shinyaku Co Ltd
TSE:4516
|
JP |
|
W
|
Waste Management Inc
DUS:UWS
|
US |
|
SJS Enterprises Ltd
NSE:SJS
|
IN |
|
T
|
Teck Resources Ltd
F:TEKB
|
CA |
|
PPG Industries Inc
NYSE:PPG
|
US |
|
S
|
Siemens Healthineers AG
DUS:SHL
|
DE |
|
Rocket Lab USA Inc
F:6RJ
|
US |
|
Strategic Elements Ltd
ASX:SOR
|
AU |
|
E
|
Experian PLC
F:J2B
|
IE |
|
L
|
London Stock Exchange Group PLC
SWB:LS4C
|
UK |
|
N
|
NRG Energy Inc
F:NRA
|
US |
|
N
|
Nordson Corp
SWB:ND1
|
US |
|
B
|
Boston Beer Company Inc
SWB:BBEA
|
US |
Fiserv Inc (FIV)’s 12-month stock price forecast through August 2027 has a consensus target of €53.25, implying 15% upside. The forecast is based on price targets from 32 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
FIV is 53.25 EUR with a low forecast of 35.75 EUR and a high forecast of 97.66 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 5 years is 2%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 5 years is 2%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 7%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 7%.
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 9%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more